Horizon Europe is the European Union’s seven-year research and innovation programme, running from 2021 to 2027. The programme’s general objective is to deliver scientific, technological, economic and societal impact from the Union’s investments in R&I, to strengthen the scientific and technological bases of the Union, and foster its competitiveness in all Member States. The programme is divided into 4 main pillars:
Horizon Europe
Horizon Europe 2021-2027_NEW
Horizon Europe Projects
AiRPaDD - Advancing Reaction Platforms for Drug Discovery
Specific programme: HORIZON TMA MSCA Doctoral Networks - Industrial Doctorates
UPV/EHU Partner Status: Coordinator
UPV/EHU PI: Enrique Gómez
Project start: 01/02/2023
Project end: 31/01/2027
Brief description: This Action will contribute to the sustainable development of European chemical industries in the coming decades by delivering an ambitious doctoral training programme that draws on expertise from industry and academia across 4 European countries. The research agenda and experiential training will grow the skills base beyond approaches that have relied upon a limited set of molecular scaffolds and a relatively small sub-set of reactions to exploit new reaction paradigms and platforms (e.g. high throughput experimentation, photoredox & electrochemistry) that meet the needs of modern drug discovery science.
info_masinformacionehurope
Contact information:
International R&D Office UPV/EHU
Email: proyectoseuropeos@ehu.es